Bright Health Group Inc. (NYSE:BHG) concluded the trading at $1.18 on Wednesday, September 21 with a fall of -0.84% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $1.19 with its price kept floating in the range of $1.13 and $1.23 on the day. Considering stock’s 52-week price range provides that BHG hit a high price of $9.58 and saw its price falling to a low level of $1.13 during that period. Over a period of past 1-month, stock came subtracting -29.34% in its value.
With its current market valuation of $818.39 million, Bright Health Group Inc. is set to declare its quarterly results on Nov 11, 2021. Analysts are in estimates of -$0.32 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -$1.48 for 2022 with estimates of that growing to -$0.77 in next year. These estimates are suggesting current year growth of 51.00% for EPS and 48.00% growth next year.
Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of $1.81 billion. They suggested that in the process company could generate revenue of as low as $1.76 billion which could climb up to $1.85 billion to hit a high. The average estimate is representing an increase of 62.80% in sales growth from that of posted by the company in the same quarter of last year. In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of $7.09 billion in 2022, which will be 75.90% more from revenue generated by the company last year.
In last 7 days, analysts came adjusting their opinions about stock’s EPS with no upward and no downward revisions, an indication which could give clearer idea about the company’s short term price movement. In contrast, when we review BHG stock’s current outlook then short term indicators are assigning it an average of 100% Sell, while medium term indicators are categorizing the stock at an average of 100% Sell. Long term indicators are suggesting an average of 100% Sell for it.
Digging deeper we become aware of the PEG ratio of the BHG stock which is currently positioned at 0. It further provides that stock’s current price level is -22.88% away from its 20-day simple moving average and is -30.97% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 27.93 while volatility remained at 10.86% over the past week which changes to 7.67% when measuring it over the past month. Average true range or ATR is currently at 0.12.
In comparing Bright Health Group Inc. (BHG)’s stock with other industry players reveals that stock’s current price change of -0.84% and that of -87.16% over the past 12 months is in competing position with that of Elevance Health Inc. (ELV) which saw its stock price fall by -2.05% in the last trading and went through an increase of 22.86% in past 12-month trading. Industry’s another major player Cigna Corporation (CI) has fall -1.09% down in previous session, but over the past year has faced a rise of 40.79%, while Humana Inc. (HUM) was also down -2.44% however its price remained floating in the green at 22.43% over the same period. Bright Health Group Inc. has a P/E ratio of 0 against that of Elevance Health Inc.’s 18.67 while Cigna Corporation is showing 16.99 for the same. On the other hand, the S&P 500 Index was down -1.71% in the last trading session while the Dow Jones Industrial closed the session lower at -1.70%.
Having a second look at Bright Health Group Inc. (NYSE:BHG) provides that stock’s average daily trading volume for 3 months was 1.76 million, while it jumped to 3.05 million when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 629.20 million.
The percentage of outstanding shares held by the insiders is 5.76% while it is 72.00% for the institutional holders. The figures also indicate that as of Jul 14, 2022, number of stock’s short shares was 11.33 million which implies a short ratio of 6.07. This shows down a 1.80% of Short Interest in company’s outstanding shares on the day. In July the standing of shares short improved as it was 14.02 million in the previous month. Subtraction of -65.70% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.